Thursday, January 20, 2022
Home Tags Active pharmaceutical ingredients

Tag: Active pharmaceutical ingredients

Govt may impose anti-dumping duty on Pharma API from China

The commerce ministry has recommended the imposition of an anti-dumping duty on a active pharmaceutical ingredients (API) from China to guard domestic players from cheap imports.

Himachal invites Pharma Industry to sign MoU for proposed API park

The state government of Himachal Pradesh has invited pharma industry stakeholders to sign a memorandum of understanding (MoU) to set up their...

Brief guidelines for bulk drug parks: DoP

The Department of Pharmaceuticals (DoP), under the Ministry of Chemicals and Fertilisers, the Government of India has issued brief guidelines for bulk...

No shortage of drug, APIs for next 3 months: Govt

Ahmedabad: The government asserted that there is no shortage of raw ingredients or medicines in the country for next three months and...

Bulk drug Cos told to pay 0.5% of turnover

The bulk drug firms located in Jeedimetla, Balanagar and Patanchereru areas on the outskirts of Hyderabad have been told to deposit 0.5...

Pharma Cos Don’t See Supply Shortage

Mumbai: Glaxosmithkline India (GSK), one of the largest manufacturers of branded paracetamol in India, said it does not anticipate any supply shortages “at the...

Pharmexcil seeks data on chinese imports

Hyderabad: The Pharmaceuticals Export Promotion Council of India has begun reaching out to drugmakers, seeking details of active pharmaceutical ingredients (APIs), key starting...

Prolongation of coronavirus could hit Indian pharma sector

New Delhi: Indian pharma firms are closely monitoring the outbreak of coronavirus in China as it could impact the supply of active pharmaceutical ingredients (API) in...

Industry recommends prefix or suffix in brand name

Industry recommends prefix or suffix in existing brand name to be allowed on change in API formulation Worried about...

India’s production of paracetamol & antibiotics could be hit: Coronavirus crisis

New Delhi: The supply of raw materials to produce top-selling antibiotics, anti-diabetic medicines and commonly used paracetamol could be hit in India...

Sub-committee on post approval changes to pharmaceutical products: DCGI

The Drugs Controller General of India (DCGI) has constituted a sub-committee to frame guidelines on post approval changes to pharmaceutical products in...

USFDA lens slow down Indian pharma exports: CII

Hyderabad: Frequent inspections of Indian plants by the US FDA and subsequent observations slow down the growth of pharma exports even as US-China trade war presents...

Latest posts

Drug alert: 33 out of 1385 samples declared as NSQ in...

Download the list of NSQ samples for December 2021: The Central Drugs Standard Control Organisation (CDSCO) has declared 33 drug samples out...

Authors

61 POSTS0 COMMENTS
30 POSTS0 COMMENTS
25 POSTS0 COMMENTS
15 POSTS0 COMMENTS
11 POSTS0 COMMENTS
11 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
5 POSTS0 COMMENTS
4 POSTS0 COMMENTS
4 POSTS0 COMMENTS
3 POSTS0 COMMENTS
2 POSTS0 COMMENTS
2 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS
1 POSTS0 COMMENTS